MedPath

Construction and Application of Database of Hebei Provincial Gastric Cancer Collaborative Network Driven by Artificial Intelligence Technology

Recruiting
Conditions
The Study Focuses on Gastric Cancer
Registration Number
NCT06506825
Lead Sponsor
Qun Zhao
Brief Summary

This clinical trial aims to construct and apply a collaborative network database for gastric cancer in Hebei Province, driven by artificial intelligence (AI) technology. The project seeks to integrate clinical data, genomic information, and treatment outcomes from multiple hospitals and research centers within the region. By leveraging advanced AI algorithms, the database will facilitate comprehensive data analysis to identify novel biomarkers, optimize therapeutic strategies, and improve patient outcomes. This initiative will also support real-time data sharing and collaboration among healthcare providers, researchers, and policymakers, ultimately enhancing the overall management and treatment of gastric cancer in Hebei Province.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
30000
Inclusion Criteria

All patients with gastric cancer

Exclusion Criteria

None

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
5-year overall survival2025-12-31

5-year overall survival

Secondary Outcome Measures
NameTimeMethod
5-year recurrence-free survival2025-12-31

5-year recurrence-free survival

Trial Locations

Locations (1)

Department of General Surgery

🇨🇳

Shijiazhuang, Hebei, China

© Copyright 2025. All Rights Reserved by MedPath